Cargando…

Retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability

AIMS: Recent studies have identified neuroretinal abnormalities in persons affected by diabetes mellitus, before the onset of microvascular alterations. However, the role of glycemic variability (GV) on early retinal neurodegeneration is still not clarified. METHODS: To explore the relationship betw...

Descripción completa

Detalles Bibliográficos
Autores principales: Picconi, Fabiana, Parravano, Mariacristina, Ylli, Dorina, Pasqualetti, Patrizio, Coluzzi, Sara, Giordani, Ilaria, Malandrucco, Ilaria, Lauro, Davide, Scarinci, Fabio, Giorno, Paola, Varano, Monica, Frontoni, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385321/
https://www.ncbi.nlm.nih.gov/pubmed/28238189
http://dx.doi.org/10.1007/s00592-017-0971-4
_version_ 1782520575636275200
author Picconi, Fabiana
Parravano, Mariacristina
Ylli, Dorina
Pasqualetti, Patrizio
Coluzzi, Sara
Giordani, Ilaria
Malandrucco, Ilaria
Lauro, Davide
Scarinci, Fabio
Giorno, Paola
Varano, Monica
Frontoni, Simona
author_facet Picconi, Fabiana
Parravano, Mariacristina
Ylli, Dorina
Pasqualetti, Patrizio
Coluzzi, Sara
Giordani, Ilaria
Malandrucco, Ilaria
Lauro, Davide
Scarinci, Fabio
Giorno, Paola
Varano, Monica
Frontoni, Simona
author_sort Picconi, Fabiana
collection PubMed
description AIMS: Recent studies have identified neuroretinal abnormalities in persons affected by diabetes mellitus, before the onset of microvascular alterations. However, the role of glycemic variability (GV) on early retinal neurodegeneration is still not clarified. METHODS: To explore the relationship between glycemic control and neuroretinal characteristics, 37 persons with Type 1 diabetes mellitus (Type 1 DM) divided into two groups with no signs (noRD) and with mild non-proliferative diabetic retinopathy (NPDR) compared to 13 healthy control participants (C) were recruited. All persons underwent an optical coherence tomography with automatic segmentation of all neuroretinal layers. Measurements of mean of nasal (N)/temporal (T)/superior (S)/inferior (I) macular quadrants for individual layer were also calculated. Metabolic control was evaluated by glycated hemoglobin (HbA1c), and indexes of GV were calculated from continuous glucose monitoring. RESULTS: The difference among the three groups in terms of RNFL thickness was significantly dependent on quadrant (F(6;132) = 2.315; p = 0.037). This interaction was due to a specific difference in RNFL-N thickness, where both Type 1 DM groups showed a similar reduction versus C (−3.9 for noDR and −4.9 for NPDR), without any relevant difference between them (−1.0). Inner nuclear layer (INL) was increased in all quadrants in the two Type 1 DM groups compared to C (mean difference = 7.73; 95% CI: 0.32–15.14, p = 0.043; mean difference = 7.74; 95% CI: 0.33–15.15, p = 0.043, respectively). A negative correlation between RNFL-N and low blood glucose index (r = −0.382, p = 0.034) and positive correlation between INL and continuous overall net glycemic action −1, −2, −4 h (r = 0.40, p = 0.025; r = 0.39, p = 0.031; r = 0.41, p = 0.021, respectively) were observed in Type 1 DM patients. The triglycerides were positively and significantly correlated to INL (r = 0.48, p = 0.011), in Type 1 DM subjects. GV and triglycerides resulted both independent predictors of increased INL thickness. No correlation was found with HbA1c. CONCLUSIONS: Early structural damage of neuroretina in persons with Type 1 DM patients is related to glucose fluctuations. GV should be addressed, even in the presence of a good metabolic control.
format Online
Article
Text
id pubmed-5385321
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-53853212017-04-24 Retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability Picconi, Fabiana Parravano, Mariacristina Ylli, Dorina Pasqualetti, Patrizio Coluzzi, Sara Giordani, Ilaria Malandrucco, Ilaria Lauro, Davide Scarinci, Fabio Giorno, Paola Varano, Monica Frontoni, Simona Acta Diabetol Original Article AIMS: Recent studies have identified neuroretinal abnormalities in persons affected by diabetes mellitus, before the onset of microvascular alterations. However, the role of glycemic variability (GV) on early retinal neurodegeneration is still not clarified. METHODS: To explore the relationship between glycemic control and neuroretinal characteristics, 37 persons with Type 1 diabetes mellitus (Type 1 DM) divided into two groups with no signs (noRD) and with mild non-proliferative diabetic retinopathy (NPDR) compared to 13 healthy control participants (C) were recruited. All persons underwent an optical coherence tomography with automatic segmentation of all neuroretinal layers. Measurements of mean of nasal (N)/temporal (T)/superior (S)/inferior (I) macular quadrants for individual layer were also calculated. Metabolic control was evaluated by glycated hemoglobin (HbA1c), and indexes of GV were calculated from continuous glucose monitoring. RESULTS: The difference among the three groups in terms of RNFL thickness was significantly dependent on quadrant (F(6;132) = 2.315; p = 0.037). This interaction was due to a specific difference in RNFL-N thickness, where both Type 1 DM groups showed a similar reduction versus C (−3.9 for noDR and −4.9 for NPDR), without any relevant difference between them (−1.0). Inner nuclear layer (INL) was increased in all quadrants in the two Type 1 DM groups compared to C (mean difference = 7.73; 95% CI: 0.32–15.14, p = 0.043; mean difference = 7.74; 95% CI: 0.33–15.15, p = 0.043, respectively). A negative correlation between RNFL-N and low blood glucose index (r = −0.382, p = 0.034) and positive correlation between INL and continuous overall net glycemic action −1, −2, −4 h (r = 0.40, p = 0.025; r = 0.39, p = 0.031; r = 0.41, p = 0.021, respectively) were observed in Type 1 DM patients. The triglycerides were positively and significantly correlated to INL (r = 0.48, p = 0.011), in Type 1 DM subjects. GV and triglycerides resulted both independent predictors of increased INL thickness. No correlation was found with HbA1c. CONCLUSIONS: Early structural damage of neuroretina in persons with Type 1 DM patients is related to glucose fluctuations. GV should be addressed, even in the presence of a good metabolic control. Springer Milan 2017-02-25 2017 /pmc/articles/PMC5385321/ /pubmed/28238189 http://dx.doi.org/10.1007/s00592-017-0971-4 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Picconi, Fabiana
Parravano, Mariacristina
Ylli, Dorina
Pasqualetti, Patrizio
Coluzzi, Sara
Giordani, Ilaria
Malandrucco, Ilaria
Lauro, Davide
Scarinci, Fabio
Giorno, Paola
Varano, Monica
Frontoni, Simona
Retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability
title Retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability
title_full Retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability
title_fullStr Retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability
title_full_unstemmed Retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability
title_short Retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability
title_sort retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385321/
https://www.ncbi.nlm.nih.gov/pubmed/28238189
http://dx.doi.org/10.1007/s00592-017-0971-4
work_keys_str_mv AT picconifabiana retinalneurodegenerationinpatientswithtype1diabetesmellitustheroleofglycemicvariability
AT parravanomariacristina retinalneurodegenerationinpatientswithtype1diabetesmellitustheroleofglycemicvariability
AT yllidorina retinalneurodegenerationinpatientswithtype1diabetesmellitustheroleofglycemicvariability
AT pasqualettipatrizio retinalneurodegenerationinpatientswithtype1diabetesmellitustheroleofglycemicvariability
AT coluzzisara retinalneurodegenerationinpatientswithtype1diabetesmellitustheroleofglycemicvariability
AT giordaniilaria retinalneurodegenerationinpatientswithtype1diabetesmellitustheroleofglycemicvariability
AT malandruccoilaria retinalneurodegenerationinpatientswithtype1diabetesmellitustheroleofglycemicvariability
AT laurodavide retinalneurodegenerationinpatientswithtype1diabetesmellitustheroleofglycemicvariability
AT scarincifabio retinalneurodegenerationinpatientswithtype1diabetesmellitustheroleofglycemicvariability
AT giornopaola retinalneurodegenerationinpatientswithtype1diabetesmellitustheroleofglycemicvariability
AT varanomonica retinalneurodegenerationinpatientswithtype1diabetesmellitustheroleofglycemicvariability
AT frontonisimona retinalneurodegenerationinpatientswithtype1diabetesmellitustheroleofglycemicvariability